Breaking News

Bioserv Appoints Pharma Technologies SVP

April 21, 2014

Schrier brings 25 years of analytical and development experience

Jay Schrier, Ph.D., has been appointed senior vice president of Pharmaceutical Technologies at Bioserv Corp.

Dr. Schrier has more than 25 years of analytical and pharmaceutical development experience and has helped create numerous cGMP-compliant analytical and pharmaceutical development departments within the pharma industry. Prior to joining the company, he was senior director of pharmaceutical development at Pacira Pharmaceuticals.

Al Hansen, chairman and chief executive officer of Bioserv Corp. and managing partner at KESA Partners, said, “We are excited to welcome someone with Dr. Schrier’s outstanding qualifications and leadership skills to our growing executive team at Bioserv. His development expertise will result in significant value creation for our manufacturing clients. Dr. Schrier will provide expertise to our clients to enable them to manufacture their products to high quality standards but in a cost-effective manner.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important